Fintech PR
KPMG LLP Opens New 30,000 Square-Foot Innovation And Technology Center In Chicago
KPMG LLP announced today the opening of the KPMG Ignition Center – Chicago, the firm’s seventh and largest Center designed to allow the firm’s clients to become better, more competitive and transform. The 30,000 square foot Ignition Center, located on the 68th floor of the Aon Center, brings together the firm’s collective capabilities across signal sensing, design thinking, data & analytics and Artificial Intelligence (AI), strategy, business process and technology.
“With the rate and pace of disruption in the market, KPMG is constantly focused on making strategic, short and long-term investments that address market disruption and support a transformation journey,” said Mike Nolan, KPMG Vice Chair, Innovation & Enterprise Solutions (I&ES). “We are excited to open our seventh and largest Ignition Center. These spaces help us to bring together our capabilities across emerging technologies, strategy and business services in a new way that represents how KPMG is transforming our business and how we help our clients transform.”
The proliferation of emerging technologies like artificial intelligence/cognitive, blockchain, cloud, augmented/virtual reality and platform business models promise greater efficiency and lower costs, but many organizations find it challenging to capitalize on these new technologies. KPMG is able to help businesses navigate the signals of disruption that are impacting their business, establish strategic approaches to evolving their business models, financial models and operating models, and design technology solutions that can support their organizational needs.
KPMG’s 2018 CEO Outlook found that 86 percent of U.S. CEOs consider their companies to be active disruptors. A vast majority see technology as the only significant disruption their business faces. KPMG Ignition Centers enable the firm to anticipate technology advances and monitor the signals of disruption in order to support the modernization of business, including human-centered design thinking and ways of working.
The firm selected Chicago for its newest KPMG Ignition Center in part due to the breadth of industry sectors and businesses located in the Chicagoland area, convenient access to transportation, and access to talent. The firm’s second-largest office, Chicago’s more than 2,500 partners and professionals serve more than 1,000 publically and privately held companies in the Chicago area across audit, tax and advisory.
“Chicago’s ability to attract and retain technology talent is critical to the work we are doing to support enterprise-wide business transformation,” said Linda Imonti, Chicago office managing principal. “Our clients represent a cross-sections of the industries and businesses that are being transformed by emerging technologies, regulatory changes and the changing customer. Having a KPMG Ignition Center in Chicago enables us to not only help solve their complex business problems, but also to attract and retain the new types of talent critical to KPMG’s continued growth.”
“Chicago’s tech scene has grown tremendously over the past several years because of our deep talent pool, global connectivity, world-class infrastructure, affordability and amazing quality of life,” said Mayor Emanuel. “KPMG’s ongoing commitment to invest in Chicago and foster the next generation of technologists in Chicago will advance our technology ecosystem for many years to come.”
The 30,000 square foot KPMG Ignition Center in Chicago incorporates:
- Innovation Lab: KPMG Innovation Labs detect and interpret signals of change, from an outside-in perspective. Using proprietary research and tools, customer insights, and robust analysis capabilities, KPMG applies design thinking for business model innovation, enabling our clients to synthesize new outlooks and translate complex signals into actions.
- Insights Center: A state-of-the-art facility to showcase the art of the possible using data & analytics and artificial intelligence (AI). Companies can engage in real-time data exploration and scenario testing, and prototype development for big data systems, data visualization, machine learning, predictive analytics, and optimization. In addition to Chicago, KPMG Insights Centers are located in New York, Frankfurt, Hong Kong, London, Paris and Sydney.
- Technology Solutions collaborates with leading technology firms to drive transformational outcomes through innovation. The integrated teams of data scientists, developers, engineers, technologists and business specialists support a vast array of enabling solutions including cyber security, Tax transformation and technology, robotics and process automation, data and analytics, HR and business transformation, and cloud-based human capital management and financials.
- Green Room: A prototyping “Garage” space. It currently houses a “retail branch of the future,” an immersive demonstration of how Cloud, AI, and Machine Learning are helping retail banks and mortgage lenders to enhance customer service and simplify complex interactions.
- A Briefing Center with a 13-person “Harkness-style” table for strategy and planning.
- The Living Room: A mindful space with natural finishes, a living wall and executive dining area for person-to-person interaction and executive dining.
KPMG Ignition Centers are located in Atlanta, Denver, Grand Rapids, New York City – midtown and downtown, and San Francisco. KPMG will open its next Ignition Center at the KPMG Lakehouse in Lake Nona, FL in 2020.
SOURCE KPMG LLP
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
“The Hainan FTP and Me”: Looking at Hainan’s Transformations
-
Latest News5 days ago
Millions of people unite around doing good on the 18th International Good Deeds Day held yesterday worldwide
-
Latest News4 days ago
Banxso Acquires Australian ASIC License, Enhancing Its Global Trading Operations
-
Latest News5 days ago
135th Canton Fair Launches a Showcase of Innovative Products of New Collection to Lead Global Market Trends
-
Latest News3 days ago
BMO Announces Election of Board of Directors
-
Latest News5 days ago
BII and FMO back BECIS with joint US$50 million financing facility supporting commercial and industrial renewables sector in South-East Asia
-
Latest News3 days ago
Vantage Markets Wins “Most Innovative Broker” Award from FXBT; Redefines Trader Empowerment
-
Latest News4 days ago
IHG Hotels & Resorts and NOVUM Hospitality sign agreement that doubles IHG’s hotel presence in Germany, launches Holiday Inn – the niu collaboration, and debuts Garner and Candlewood Suites brands